MaxCyte, Inc. (MXCT) News
Track canonical SquawkNews coverage tagged to MXCT, MaxCyte, Inc.. This hub brings together deduplicated headlines about alpaca us equities, markets catalysts, earnings, analyst actions, and wider market events so traders can review how a developing story changed over time. It contains 3 indexed stories across 2 publication days and is ordered by the same first-publication timeline used by LiveCast.
L
MaxCyte Affirms FY2026 Sales Guidance
MaxCyte affirms FY2026 sales outlook of $30.000M-$32.000M
EARNINGS | Aug 12, 2026, 08:09 PM UTC
L
MXCT Reports Q2 2026 Financial Results
MaxCyte reports second quarter 2026 financial results
EARNINGS | Aug 12, 2026, 08:07 PM UTC
L
MXCT maxcyte® announces multi-platform technology license partnership with genentech® to advance cell therapy development Maxcyte - genentec
MXCT maxcyte® announces multi-platform technology license partnership with genentech® to advance cell therapy development Maxcyte - genentech to access Maxcyte expert gtx platform and technologies for cell therapy workfl
EQUITY | Jul 21, 2026, 12:46 PM UTC